2026医疗展望：百家公司港股排队，医疗板块能否再创「神话」

Core Insights - The medical sector is experiencing both "explosive growth" and "cooling" trends as companies like Jingfeng Medical and Beixin Life go public, with over 100 medical companies waiting for IPOs in Hong Kong amid tightening regulations [1][2] - The performance of new drug IPOs in 2026 is expected to be significantly differentiated, with investors becoming more selective and focusing on companies with successful overseas BD cases and clear product timelines [2][3] - The AI-driven pharmaceutical sector is gaining traction, with companies like InSilico Medicine and Huasheng Zhiyuan achieving significant BD transactions, indicating a growing interest in AI's potential in drug development [1][5][11] Medical Device Sector - The medical device sector is recovering at a slower pace compared to the innovative drug sector, facing challenges such as geopolitical issues and difficulties in international expansion [2][24] - Investment in the medical device market is currently low but is expected to gradually improve, with opportunities in high-end imaging, surgical robots, and AI-driven devices [22][24] - The export of innovative medical devices is anticipated to improve in 2026, with leading domestic manufacturers enhancing product quality to compete in international markets [24][25] BD Transactions and Market Trends - The global share of China's new drug BD transactions is expected to continue rising, although the growth rate may slow due to geopolitical factors and changing perceptions of value [5][6] - The oncology treatment landscape is becoming crowded, prompting a shift in focus towards autoimmune, metabolic, and central nervous system-related new drugs [7][8] - AI in drug development is seen as a significant trend, with companies needing to leverage data effectively to succeed in clinical applications [11][12] Investment Opportunities - The investment landscape for medical devices is characterized by a focus on therapeutic devices, with a shift from diagnostic to treatment-oriented products [17][22] - There is a growing interest in consumer medical devices, particularly those enhanced by AI, which are expected to see increased demand and market penetration [13][14] - The need for innovative solutions in areas like cardiovascular and neurological treatments remains strong, with potential for significant market growth [17][24]